-
Mashup Score: 1Trials of AI Interventions Must Be Preregistered - 1 month(s) ago
Artificial intelligence (AI) must meet the same bar for clinical evidence as other clinical interventions. Trials that start enrolling patients after January 1, 2025 and that use an AI intervention…
Source: ai.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8The effect of health-care privatisation on the quality of care - 2 month(s) ago
Over the past 40 years, many health-care systems that were once publicly owned or financed have moved towards privatising their services, primarily through outsourcing to the private sector. But what has the impact been of privatisation on the quality of care? A key aim of this transition is to improve quality of care through increased market competition along with the benefits of a more flexible and patient-centred private sector. However, concerns have been raised that these reforms could result in worse care, in part because it is easier to reduce costs than increase quality of health care.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
In May 2018, the Secretariat for the World Health Organization Framework Convention on Tobacco Control convened a meeting to discuss the potential for reducing the addictiveness of tobacco products. A central focus was to review research findings on the …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
Does fluorouracil, leucovorin, liposomal irinotecan and oxaliplatin (NALIFIROX) confer a survival benefit as first-line treatment for patients with metastatic pancreatic cancer compared with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 573Long covid—an update for primary care - 3 month(s) ago
### What you need to know This article updates and extends a previous BMJ Practice Pointer published in August 2020 when almost no peer reviewed research or evidence based guidance on the condition was available.1 In this update we outline how clinicians might respond to the questions that patients ask. The term “long covid”2 refers to prolonged symptoms following infection with SARS-CoV-2 that are not explained by an alternative diagnosis. It embraces the National Institute for Health and Care Excellence (NICE)’s terms “ongoing symptomatic covid-19” (symptoms lasting 4-12 weeks) and “post covid-19 syndrome” (symptoms beyond 12 weeks),3 the US Centers for Disease Control and Prevention’s group of “post-covid conditions,”4 and the World Health Organization’s “post covid-19 condition.”5 In mid-2022, approximately 70% of the UK adult population had been infected with SARS-CoV-2.6 Of these, almost 2 million report covid-19 symptoms persisting for more than four weeks; 807 000 (41% of all p
Source: www.bmj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
Parks Canada is warning drivers not to stop while on highways to let moose lick their cars this winter, as more moose venture down to highways to fuel their salt intake.
Source: www.cbc.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Opinion: What if ‘Axe the Tax’ leaves most Canadians worse off? - 5 month(s) ago
The Trudeau government has done a terrible job of communicating how its carbon tax revenue-recycling system works – and how most Canadians benefit from it
Source: www.theglobeandmail.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer - 5 month(s) ago
The emergence of the precision medicine paradigm in oncology has led to increasing interest in the integration of real-world data (RWD) into cancer clinical research. As sources of real-world evidence (RWE), such data could potentially help address the uncertainties that surround the adoption of novel anticancer therapies into the clinic following their investigation in clinical trials. At present, RWE-generating studies which investigate antitumour interventions seem to primarily focus on collecting and analysing observational RWD, typically forgoing the use of randomisation despite its methodological benefits.
Source: www.ejcancer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10This Is How the FDA Plans to Fight Health Misinformation - 7 month(s) ago
Another challenge for the FDA is to get the public to trust what they’re saying in the first place.
Source: www.bloomberg.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 66Variant-adapted COVID-19 booster vaccines - 7 month(s) ago
Current vaccines should be tailored to combat future SARS-CoV-2 variants
Source: www.science.orgCategories: Latest Headlines, Partners & KOLsTweet-
COVID VACCINES: My takeaways: 1) Unclear need variant-specific vaccines (virus changes; immunity adaptive); 2) B cell immunity forms, works; 3) Nuance in who needs boosters (e.g. older people); 4) other vaccines (e.g. whole virus; show more epitopes) https://t.co/jdgtZYrypo
-
COVID VACCINES: What I took from this: 1) Unclear need variant-specific vaccines every year (virus changes a lot; immunity adaptive); 2) B cell immunity forms, works; 3) Nuance in who needs boosters (e.g. older people); 4) try other vaccine platforms too https://t.co/jdgtZYrypo
-
RT @bradwouters: Trials of AI Interventions Must Be Preregistered | NEJM AI https://t.co/xUsCLOTmuG